Find clinical trials in your area
Search by disease and location to discover available clinical trials matching your criteria.
↓
Matched clinical trials
Study Comparing Sacituzumab Govitecan Alone and with Pembrolizumab for Patients with Low-Risk, Triple-Negative Early Breast Cancer
Recruiting
Investigated diseases:Investigated drugs:
Neoadjuvant Sacituzumab Govitecan and Pembrolizumab for Patients with Clinical Stage II-III Triple-Negative Early Breast Cancer
Not yet recruiting
Investigated diseases:Investigated drugs:
Study of Trastuzumab, Pertuzumab, and Chemotherapy Combination with Response-Guided Treatment for Patients with HER2-Positive Breast Cancer
Not recruiting
Investigated diseases:Investigated drugs:
Study on Preoperative Treatment for HER2 Positive Breast Cancer Using Docetaxel, Pertuzumab, and Trastuzumab in Patients with Primary Breast Cancer
Not recruiting
Investigated diseases:Investigated drugs:



